MEMBREX Trademark

Trademark Overview

On Monday, December 14, 2015, a trademark application was filed for MEMBREX with the United States Patent and Trademark Office. The USPTO has given the MEMBREX trademark a serial number of 86847758. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, April 21, 2023. This trademark is owned by Metaclipse Therapeutics Corporation. The MEMBREX trademark is filed in the Medical & Beauty Services & Agricultural Services category with the following description:

Providing medical services in the field of Cancer Immunotherapy
membrex

General Information

Serial Number86847758
Word MarkMEMBREX
Filing DateMonday, December 14, 2015
Status710 - CANCELLED - SECTION 8
Status DateFriday, April 21, 2023
Registration Number5061033
Registration DateTuesday, October 11, 2016
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 31, 2016

Trademark Statements

Goods and ServicesProviding medical services in the field of Cancer Immunotherapy

Classification Information

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, April 21, 2023
Primary Code044
First Use Anywhere DateThursday, September 24, 2015
First Use In Commerce DateThursday, September 24, 2015

Trademark Owner History

Party NameMetaclipse Therapeutics Corporation
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressAtlanta, GA 30340
Party NameMetaclipse Therapeutics Corporation
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressAtlanta, GA 30340
Party NameMetaclipse Therapeutics Corporation
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressAtlanta, GA 30340

Trademark Events

Event DateEvent Description
Friday, April 21, 2023CANCELLED SEC. 8 (6-YR)
Monday, October 11, 2021COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Tuesday, October 11, 2016REGISTERED-PRINCIPAL REGISTER
Thursday, September 8, 2016NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Wednesday, September 7, 2016ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Tuesday, September 6, 2016STATEMENT OF USE PROCESSING COMPLETE
Thursday, August 4, 2016USE AMENDMENT FILED
Monday, August 29, 2016CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, August 4, 2016TEAS STATEMENT OF USE RECEIVED
Tuesday, July 26, 2016NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, May 31, 2016OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, May 31, 2016PUBLISHED FOR OPPOSITION
Wednesday, May 11, 2016NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, April 14, 2016APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, April 1, 2016TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, April 1, 2016CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, April 1, 2016TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, March 30, 2016NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, March 30, 2016NON-FINAL ACTION E-MAILED
Wednesday, March 30, 2016NON-FINAL ACTION WRITTEN
Wednesday, March 30, 2016ASSIGNED TO EXAMINER
Thursday, December 17, 2015NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, December 17, 2015NEW APPLICATION ENTERED

Related Keywords

membrex cancer immunotherapy field services medical providing